Literature DB >> 1612490

Computed tomography in predicting gall stone solubility: a prospective trial.

A Caroli1, G Del Favero, F Di Mario, F Spigariol, P Scalon, T Meggiato, C Zambelli, R Naccarato.   

Abstract

This prospective study was undertaken to evaluate the correlation between densitometric values of gall stones assessed by computed tomography and the success rate of litholytic therapy in 28 patients eligible for oral treatment. A densitometric study of the stones was performed in all patients before treatment. A cut off point of 60 Hounsfield units (HU) was chosen to divide the subjects into two groups--group 1, 14 patients with low density stones (less than 60 HU) and group 2, 14 patients with high density stones (greater than 60 HU). All patients were treated with ursodeoxycholic acid (8-10 mg/kg/day) for 12 months and followed up by ultrasound. In group 1, dissolution was complete in 50% of the patients and partial in a further 20%. In group 2 patients, complete dissolution was not observed but 33% showed partial dissolution. The number of patients with total dissolution at 12 months was significantly higher in group 1 compared with group 2 (p less than 0.02). These results suggest that computed tomography can be used to select patients with a better likelihood of successful stone dissolution after bile acid therapy.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1612490      PMCID: PMC1379305          DOI: 10.1136/gut.33.5.698

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  20 in total

1.  Analysis of radiolucent gallstones by computed tomography for in vivo estimation of stone components.

Authors:  A Rambow; M Staritz; U Wosiewitz; P Mildenburger; M Thelen; K H Meyer zum Büschenfelde
Journal:  Eur J Clin Invest       Date:  1990-08       Impact factor: 4.686

2.  Dissolution of cholesterol gallbladder stones by methyl tert-butyl ether administered by percutaneous transhepatic catheter.

Authors:  J L Thistle; G R May; C E Bender; H J Williams; A J LeRoy; P E Nelson; C J Peine; B T Petersen; J E McCullough
Journal:  N Engl J Med       Date:  1989-03-09       Impact factor: 91.245

3.  In vitro dissolution of gallstones with MTBE: correlation with characteristics at CT and MR imaging.

Authors:  R L Baron; S J Kuyper; S P Lee; C A Rohrmann; W P Shuman; J A Nelson
Journal:  Radiology       Date:  1989-10       Impact factor: 11.105

4.  CT evaluation of gallstones in vitro: correlation with chemical analysis.

Authors:  R L Baron; C A Rohrmann; S P Lee; W P Shuman; S A Teefey
Journal:  AJR Am J Roentgenol       Date:  1988-12       Impact factor: 3.959

5.  Fragmentation of gallstones using extracorporeal shock waves: an in vitro study.

Authors:  R Schachler; T Sauerbruch; U Wosiewitz; J Holl; D Hahn; R Denk; M Neubrand; G Paumgartner
Journal:  Hepatology       Date:  1988 Jul-Aug       Impact factor: 17.425

6.  Evaluation of radiographic lucency or opaqueness of gallstones as a means of identifying cholesterol or pigment stones. Correlation of lucency or opaqueness with calcium and mineral.

Authors:  B W Trotman; E J Petrella; R D Soloway; H M Sanchez; T A Morris; W T Miller
Journal:  Gastroenterology       Date:  1975-06       Impact factor: 22.682

7.  Chemical composition of gallstones resistant to dissolution therapy with chenodeoxycholic acid.

Authors:  M J Whiting; V Jarvinen; J M Watts
Journal:  Gut       Date:  1980-12       Impact factor: 23.059

8.  Final outcome of ursodeoxycholic acid treatment in 126 patients with radiolucent gallstones.

Authors:  D Gleeson; D C Ruppin; A Saunders; G M Murphy; R H Dowling
Journal:  Q J Med       Date:  1990-07

9.  Combination therapy with oral ursodeoxycholic and chenodeoxycholic acids: pretreatment computed tomography of the gall bladder improves gall stone dissolution efficacy.

Authors:  J R Walters; K A Hood; D Gleeson; J P Ellul; A Keightley; G M Murphy; R H Dowling
Journal:  Gut       Date:  1992-03       Impact factor: 23.059

10.  Efficacy and safety of a combination of chenodeoxycholic acid and ursodeoxycholic acid for gallstone dissolution: a comparison with ursodeoxycholic acid alone.

Authors:  M Podda; M Zuin; P M Battezzati; C Ghezzi; C de Fazio; M L Dioguardi
Journal:  Gastroenterology       Date:  1989-01       Impact factor: 22.682

View more
  11 in total

1.  Gallstone dissolution with oral bile acid therapy. Importance of pretreatment CT scanning and reasons for nonresponse.

Authors:  S P Pereira; M J Veysey; C Kennedy; S H Hussaini; G M Murphy; R H Dowling
Journal:  Dig Dis Sci       Date:  1997-08       Impact factor: 3.199

Review 2.  Evidence-based clinical practice guidelines for cholelithiasis 2016.

Authors:  Susumu Tazuma; Michiaki Unno; Yoshinori Igarashi; Kazuo Inui; Kazuhisa Uchiyama; Masahiro Kai; Toshio Tsuyuguchi; Hiroyuki Maguchi; Toshiyuki Mori; Koji Yamaguchi; Shomei Ryozawa; Yuji Nimura; Naotaka Fujita; Keiichi Kubota; Junichi Shoda; Masami Tabata; Tetsuya Mine; Kentaro Sugano; Mamoru Watanabe; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2016-12-10       Impact factor: 7.527

3.  Duodenal bile examination in identifying potential non-responders to bile salt treatment and its comparison with gall bladder bile examination.

Authors:  D K Agarwal; G Choudhuri; V A Saraswat; T S Negi; V K Kapoor; R Saxena
Journal:  Gut       Date:  1994-01       Impact factor: 23.059

4.  Prospective, multicenter study on value of computerized tomography (CT) in gallstone disease in predicting response to bile acid therapy.

Authors:  M L Petroni; R P Jazrawi; A Grundy; A Lanzini; M G Pigozzi; A Biasio; K W Heaton; J Virjee; T C Northfield
Journal:  Dig Dis Sci       Date:  1995-09       Impact factor: 3.199

5.  Composition of gall bladder stones associated with octreotide: response to oral ursodeoxycholic acid.

Authors:  S H Hussaini; S P Pereira; G M Murphy; C Kennedy; J A Wass; G M Besser; R H Dowling
Journal:  Gut       Date:  1995-01       Impact factor: 23.059

6.  Symptomatic versus silent gallstones. Radiographic features and eligibility for nonsurgical treatment.

Authors:  E Ros; R Valderrama; C Bru; L Bianchi; J Terés
Journal:  Dig Dis Sci       Date:  1994-08       Impact factor: 3.199

7.  Gallbladder stone recurrence after medical treatment. Do gallstones recur true to type?

Authors:  S P Pereira; S H Hussaini; C Kennedy; R H Dowling
Journal:  Dig Dis Sci       Date:  1995-12       Impact factor: 3.199

Review 8.  Pharmacological treatment of gallstones. Practical guidelines.

Authors:  A Lanzini; T C Northfield
Journal:  Drugs       Date:  1994-03       Impact factor: 9.546

9.  Direct dissolution of gallstones with methyl tert-butyl ether (MTBE) via endoscopic transpapillary catheterization in the gallbladder (ETCG).

Authors:  N Uchida; T Nakatsu; S Hirabayashi; A Minami; H Fukuma; T Ezaki; S A Morshed; C Fuke; K Ameno; I Ijiri
Journal:  J Gastroenterol       Date:  1994-08       Impact factor: 7.527

10.  Comparison on Response and Dissolution Rates Between Ursodeoxycholic Acid Alone or in Combination With Chenodeoxycholic Acid for Gallstone Dissolution According to Stone Density on CT Scan: Strobe Compliant Observation Study.

Authors:  Jae Min Lee; Jong Jin Hyun; In Young Choi; Suk Keu Yeom; Seung Young Kim; Sung Woo Jung; Young Kul Jung; Ja Seol Koo; Hyung Joon Yim; Hong Sik Lee; Sang Woo Lee; Chang Duck Kim
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.